This independent CME/CE activity is supported by educational grants from Bristol-Myers Squibb and Gilead Sciences, Inc.
The Advanced Certificate Program in Chronic Hepatitis B Management IV
Bridging Cultural Differences to Improve HBV Treatment
in Asian and Other Diverse Communities
  1. Curriculum V
  2. Curriculum IV
  3. Curriculum III
  4. Full Course List

Currently Available

Course Title Curriculum Faculty Release Date
Expert Insight Into: Current Best Practices in Hepatitis B Treatment: Optimizing Response while Avoiding Resistance—Article Review (HBV4.18) 1880.13 IV Di Bisceglie Dec 2009
Expert Insight Into: Clinical Outcomes of HBV Superinfection in Chronic Carriers of HCV—Article Review (HBV4.17) 1880.12 IV Kim Nov 2009
Expert Insight Into: Liver Fibrosis: Consensus Recommendations of the Asian Pacific Association for the Study of the Liver (APASL) —Article Review (HBV4.16) 1880.11 IV Kim Nov 2009
Expert Insight Into: Renal Dysfunction in Asian American Patients with Chronic Hepatitis B Treated with an Oral Nucleotide Analogue—Article Review (HBV4.15) 1880.10 IV Han Oct 2009
Case Study: HBsAg-Positive, Anti-HBe-Negative Black Immigrant from Somalia—Tx Reporter e-Newsletter (HBV4.14) 1881.04 IV Di Bisceglie
Kim		 Oct 2009
Expert Insight Into: Early Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response to Interferon alfa in HBeAg-Negative Patients—Article Review (HBV4.13) 1880.09 IV Tsai Aug 2009
Expert Insight Into: Interferon vs Nucleoside Analog vs Combination Interferon/Nucleoside Analog in the Treatment of Chronic Hepatitis D Virus (HDV) Infection—Article Review (HBV4.12) 1880.08 IV Gish Jul 2009
Case Study: HBeAg-Negative Turkish Patient—Tx Reporter e-Newsletter (HBV4.11) 1881.03 IV Gish
Han		 Jul 2009
Expert Insight Into: Long-Term Chronic HBV Therapy with Investigational Nucleoside Associated with Myopathy

Based on the article:
Long-Term Therapy with Clevudine for Chronic Hepatitis B Can Be Associated with Myopathy Characterized by Depletion of Mitochondrial DNA—Article Review (HBV4.10) 1880.07		 IV Han Jun 2009
Expert Insight Into: Is There a Meaningful Serum HBV DNA Cutoff Level for Therapeutic Decisions in HBeAg-Negative Chronic HBV Infection?—Article Review (HBV4.09) 1880.06 IV Tsai May 2009
Case Study: Chinese-Born HBeAg-Positive Pregnant Patient—Tx Reporter e-Newsletter (HBV4.08) 1881.02 IV Di Bisceglie
Han		 May 2009
Expert Insight Into: Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for Chronic Hepatitis B—Article Review (HBV4.07) 1880.05 IV Gish Apr 2009
New HBV Screening Guidelines from the CDC: Emphasis on Immigrants from Endemic Areas and Others at Risk for HBV—Audio Interview (HBV4.06) 1882 IV Di Bisceglie
Tsai
Ward		 Apr 2009
Expert Insight Into: Treatment Recommendations for Chronic Hepatitis B: An Evaluation of Current Guidelines Based on a Natural History Study in the United States—Article Review (HBV4.05) 1880.04 IV Kim Apr 2009
Case Study: HBeAg-Positive Vietnamese Patient—Tx Reporter e-Newsletter (HBV4.04) 1881.01 IV Gish
Tsai		 Mar 2009
Expert Insight Into: Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation During Chemotherapy—Article Review (HBV4.03) 1880.03 IV Di Bisceglie Feb 2009
Expert Insight Into: Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection—Article Review (HBV4.02) 1880.02 IV Kim Jan 2009
Expert Insight Into: Seroepidemiology of Hepatitis B Virus Infection: Analysis of Mass Screening in Hawaii—Article Review (HBV4.01) 1880.01 IV Han Jan 2009